TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
EBS

Emergent Biosolutions Inc

Healthcare · Drug Manufacturers - Specialty & Generic

7.00$ +4.0% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Emergent Biosolutions Inc (EBS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 95.3% of the shares are freely tradable; institutional investors hold 86.5%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 86.5%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 3.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 95.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 21.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 51Mio.

Largest Shareholders

Institutions

Institutions EBS
Name Stake (%) Shares Change (%) Date
BlackRock Inc 8.47 4,341,462 +2.0 03/31/2026
Dimensional Fund Advisors, Inc. 6.00 3,076,646 +11.6 06/30/2026
State Street Corp 5.56 2,849,701 +5.7 03/31/2026
American Century Companies Inc 5.40 2,770,448 +14.2 06/30/2026
Vanguard Capital Management, LLC 4.40 2,257,995 +0.0 03/31/2026
LSV Asset Management 3.31 1,695,851 +89.1 06/30/2026
Charles Schwab Investment Management Inc 2.94 1,506,075 -7.0 03/31/2026

Funds

Funds EBS
Name Stake (%) Shares Change (%) Date
Avantis US Small Cap Value ETF 5.42 2,781,470 +0.1 08/31/2026
State Street® SPDR® S&P® Biotech ETF 3.51 1,800,702 -1.1 08/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 3.03 1,554,116 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?